EFFECT OF GNRH-ANALOG TREATMENT WITH A DEPOT-PREPARATION IN PATIENTS WITH ENDOMETRIOSIS

被引:0
|
作者
SCHWEPPE, KW
机构
来源
MEDIZINISCHE WELT | 1994年 / 45卷 / 05期
关键词
ENDOMETRIOSIS; MEDICINE THERAPY; GNRH-AGONISTS; PELVISCOPIC SURGERY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
52 patients with proven endometriosis by pelviscopy and histology were treated for 6 month with a depotpreparation containing 3,6 mg Goserelin monthly. The subjective symptoms improved fast and significantly and three quarters of the patients stayed free of symptoms during the follow-up period of six months. A control pelviscopy after treatment showed a reduction of size and amount of implants and cysts independent of the primary stage of endometriosis. The objective effectivity of this substance compares favorable with the most potent treatment schedules of the past. Treatment induced hypoestrogenic side effects were claimed in 35 to 85 percent of women - such as hot flushes, dryness of the vagina, sweating, decreased libido. Pathologic changes of metabolic parameters could not be observed.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [31] Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients with endometriosis in vitro
    Huang, Fengying
    Wang, Huanping
    Zou, Ying
    Liu, Qiuhong
    Cao, Jing
    Yin, Tuanfang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (11): : 2487 - 2496
  • [32] EFFECT OF THE GNRH ANALOG BUSERELIN ON THE SERUM LEVELS OF SEXUAL HORMONES IN RELATION TO THE INITIATION AND DURATION OF TREATMENT
    URBANCSEK, J
    RABE, T
    GOR, U
    SCHULTE, B
    GRUNWALD, K
    PAPP, Z
    RUNNEBAUM, B
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1991, 51 (08) : 617 - 625
  • [33] Effects of combined treatment with a GnRH-analog and growth hormone on GH secretion, IGF-I and IGFBP-3 levels in pubertal short children born small for gestational age (SGA)
    van der Kaay, Danielle C. M.
    Koelega, A. C. S. Hokken
    HORMONE RESEARCH, 2006, 65 : 167 - 168
  • [34] PHARMACOKINETIC AND ENDOCRINOLOGIC PARAMETERS OF A SLOW-RELEASE DEPOT PREPARATION OF THE GNRH ANALOG ICI 118630 (ZOLADEX) COMPARED WITH A SUBCUTANEOUS BOLUS AND CONTINUOUS SUBCUTANEOUS INFUSION OF THE SAME DRUG IN PATIENTS WITH PROSTATIC-CANCERP
    PERREN, TJ
    CLAYTON, RN
    BLACKLEDGE, G
    BAILEY, LC
    HOLDER, G
    LYNCH, SS
    ARKELL, DG
    COTTAM, J
    FARRAR, D
    YOUNG, CH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) : 39 - 43
  • [35] EFFECTS OF LONG-TERM GNRH ANALOG TREATMENT ON HORMONE LEVELS AND SPERMATOGENESIS IN PATIENTS WITH CARCINOMA OF THE PROSTATE
    LUNGLMAYR, G
    GIRSCH, E
    MEIXNER, EM
    VIEHBERGER, G
    BIEGLMAYER, C
    UROLOGICAL RESEARCH, 1988, 16 (04): : 315 - 319
  • [36] Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial
    Gong, Lili
    Zhang, Shaofen
    Han, Yi
    Long, Qiqi
    Zou, Shien
    Cao, Yuankui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (08): : 848 - 853
  • [37] EXPERIENCE WITH THE GNRH ANALOG BUSERELIN IN THE TREATMENT OF 122 PROSTATIC-CANCER PATIENTS FOLLOWED FOR 4 YEARS
    WENDEROTH, UK
    JACOBI, GH
    ANTICANCER RESEARCH, 1986, 6 (03) : 378 - 379
  • [38] The aromatase inhibitor letrozole prevents the flare-up effect in endometriosis patients treated with a GnRH agonist.
    Bedaiwy, M. A.
    Casper, R. F.
    FERTILITY AND STERILITY, 2006, 86 : S260 - S260
  • [39] HORMONAL CHANGES UNDER TREATMENT OF MALE-PATIENTS WITH DELAYED PUBERTY BY INTRANASAL APPLICATION OF GONADOTROPIN-RELEASING HORMONE (GNRH) OR OF A POTENT GNRH ANALOG
    HAPP, J
    SCHMITZ, V
    CORDES, U
    KRAUSE, U
    BEYER, J
    ACTA ENDOCRINOLOGICA, 1979, 91 : 134 - 134
  • [40] TREATMENT WITH A LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG (BUSERELIN) IN DANAZOL-RESISTANT ENDOMETRIOSIS PATIENTS
    FRANSSEN, AMHW
    ROLLAND, R
    CHADHA, DR
    WILLEMSEN, WNP
    VEMER, HM
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1986, 23 (5-6) : 379 - 386